|||
Pathway ID™ is designed on Model-Based Systems Engineering (MBSE) principles, providing a structured, compliant, and scalable approach to drug-device combinations that unlock new therapeutic potential.
Pathway ID™ is the entrypoint into DTx Discovery.
We integrate Pathway ID™ processes within Target Product Profiles (TPP) to ensure seamless compatibility and scalability for drug-device combinations. This approach allows for efficient development and ensures that the digital components align perfectly with drug TPPs, enabling cutting-edge, compliant, and adaptable solutions.
Get in touch to schedule a tailored primer workshop for your team. Designed for Business Development professionals, we’ll translate the science and risks behind DTx and smart medication into strategic pathways. Discover new possibilities.
| Pathway ID™ Tier 1 | Pathway ID™ Tier 2 |
|---|---|
| Support | Adjacent |
| Priming | Concurrent |
| Maintenance | Chronotherapy |
| (Medical device risk class I & IIa) | (Medical device risk class IIb & IIb) |
By integrating devices with therapies, we drive innovation, enhance patient outcomes, and create long-term value. Our modular approach allows for seamless adaptation, ensuring that your products meet regulatory standards while remaining flexible for future advancements.
Smart Medications > Deep Dive > Systems Medicine
